• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.

作者信息

Myöhänen H T, Stephens R W, Hedman K, Tapiovaara H, Rønne E, Høyer-Hansen G, Danø K, Vaheri A

机构信息

Department of Virology, University of Helsinki, Finland.

出版信息

J Histochem Cytochem. 1993 Sep;41(9):1291-301. doi: 10.1177/41.9.8394852.

DOI:10.1177/41.9.8394852
PMID:8394852
Abstract

Pro-urokinase (pro-uPA) and activated uPA are confined to focal adhesions and cell-cell contacts. We studied the distribution of the uPA receptor (uPAR) on human fibroblasts (HES) and rhabdomyosarcoma (RD) cells by immunofluorescence and immunoelectron microscopy. Two monoclonal antibodies (MAb) utilized were against uPAR: MAb R4, which reacts with occupied and unoccupied uPAR, was concentrated at focal adhesions; MAb R3 reacting with unoccupied receptor stained cell surfaces diffusely. MAb R4 stained cell-cell contacts, tips of microspikes, and co-localized with vinculin. Of the matrix and integrin components tested, alpha v beta 3 integrin was found at focal adhesions but more centrally than uPAR. Since uPAR is anchored to the plasma membrane through a GPI lipid, we studied its mobility by antibody-induced clustering. This revealed that unoccupied uPAR was relatively mobile; MAb R3 redistributed it to clusters. In contrast, uPAR R4 and uPA antibodies at the focal contact sites remained mostly within focal contacts. Addition of exogenous uPA resulted in loss of R3 staining and increase of uPA in focal adhesions. These results suggest that occupancy of the receptor with uPA is associated with localization to cell contact sites and restricted lateral mobility.

摘要

相似文献

1
Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.
J Histochem Cytochem. 1993 Sep;41(9):1291-301. doi: 10.1177/41.9.8394852.
2
The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.尿激酶型纤溶酶原激活物(uPA)受体和玻连蛋白的生长调节素B区域将uPA定位于微血管内皮细胞的粘着斑。
Matrix Biol. 2007 Jun;26(5):359-70. doi: 10.1016/j.matbio.2007.01.009. Epub 2007 Feb 6.
3
Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.利用单克隆抗体鉴别细胞表面小鼠尿激酶型纤溶酶原激活物受体的不同形式
J Immunol Methods. 2008 Nov 30;339(1):55-65. doi: 10.1016/j.jim.2008.08.002. Epub 2008 Aug 30.
4
The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae.尿激酶型纤溶酶原激活物受体,一种糖基磷脂酰肌醇连接蛋白,定位于小窝。
J Cell Biol. 1995 Apr;129(2):335-44. doi: 10.1083/jcb.129.2.335.
5
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.利用一组单克隆抗体研究可溶性和受体结合型尿激酶在人乳腺癌中的组织分布。
Cancer Res. 1994 Oct 15;54(20):5445-54.
6
Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator.白细胞和肿瘤细胞在底物上的细胞周围蛋白水解作用:局灶性激活及尿激酶型纤溶酶原激活剂的作用
Histochem Cell Biol. 2004 Apr;121(4):299-310. doi: 10.1007/s00418-004-0639-3. Epub 2004 Mar 20.
7
Urokinase anchors uPAR to the actin cytoskeleton.尿激酶将尿激酶型纤溶酶原激活物受体(uPAR)锚定到肌动蛋白细胞骨架上。
Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2967-77. doi: 10.1167/iovs.04-0030.
8
Localization of urokinase type plasminogen activator to focal adhesions requires ligation of vitronectin integrin receptors.尿激酶型纤溶酶原激活剂定位于粘着斑需要玻连蛋白整合素受体的连接。
Cell Adhes Commun. 2000;7(6):477-90. doi: 10.3109/15419060009040305.
9
Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.乳腺丝抑蛋白通过与尿激酶型纤溶酶原激活剂/尿激酶型纤溶酶原激活剂受体系统的新型相互作用来延缓细胞脱离。
Cancer Res. 2006 Apr 15;66(8):4173-81. doi: 10.1158/0008-5472.CAN-05-3514.
10
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.尿激酶型纤溶酶原激活物受体(uPAR)在血液和骨髓细胞上的结构、功能及表达
Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398.

引用本文的文献

1
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.尿激酶型纤溶酶原激活剂(uPA)及其受体(uPAR)的多方面作用:诊断、预后及治疗应用
Front Oncol. 2018 Feb 12;8:24. doi: 10.3389/fonc.2018.00024. eCollection 2018.
2
Human sprouty1 suppresses urokinase receptor-stimulated cell migration and invasion.人类Sprouty1蛋白抑制尿激酶受体刺激的细胞迁移和侵袭。
ISRN Biochem. 2013 Sep 12;2013:598251. doi: 10.1155/2013/598251. eCollection 2013.
3
Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
肿瘤相关可溶性 uPAR 定向的内皮细胞迁移和肿瘤血管生成。
Oncogenesis. 2013 Jun 24;2(6):e53. doi: 10.1038/oncsis.2013.19.
4
MMP-9 and uPAR regulated glioma cell migration.MMP-9 和 uPAR 调控神经胶质瘤细胞迁移。
Cell Adh Migr. 2012 Nov-Dec;6(6):509-12. doi: 10.4161/cam.21673. Epub 2012 Oct 17.
5
Integrin α9β1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway.整合素 α9β1 通过 SSAT 和 Kir4.2 钾通道通路介导脑胶质母细胞瘤中的细胞迁移。
Cell Signal. 2012 Jan;24(1):272-81. doi: 10.1016/j.cellsig.2011.09.011. Epub 2011 Sep 17.
6
A deficiency of uPAR alters endothelial angiogenic function and cell morphology.尿激酶型纤溶酶原激活物受体(uPAR)缺乏会改变内皮细胞的血管生成功能和细胞形态。
Vasc Cell. 2011 May 2;3(1):10. doi: 10.1186/2045-824X-3-10.
7
Regulation of cell signalling by uPAR.尿激酶型纤溶酶原激活物受体(uPAR)对细胞信号的调节。
Nat Rev Mol Cell Biol. 2010 Jan;11(1):23-36. doi: 10.1038/nrm2821.
8
Role of integrin alpha(v)beta3 in the early phase of liver metastasis: PET and IVM analyses.整合素α(v)β3在肝转移早期阶段的作用:PET和IVM分析。
Clin Exp Metastasis. 2002;19(8):717-25. doi: 10.1023/a:1021356019563.
9
Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.被占据的尿激酶受体(uPAR)与低密度脂蛋白受体相关蛋白的直接结合是uPAR内吞作用和细胞表面尿激酶活性调节所必需的。
Mol Biol Cell. 2001 May;12(5):1467-79. doi: 10.1091/mbc.12.5.1467.
10
Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin.Rac介导细胞骨架重排以及由尿激酶型纤溶酶原激活物受体与玻连蛋白结合所诱导的细胞运动性增加。
J Cell Biol. 2001 Mar 19;152(6):1145-57. doi: 10.1083/jcb.152.6.1145.